Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16(7):411–28. https://doi.org/10.1038/s41575-019-0145-7.
Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598–606. https://doi.org/10.1016/j.jhep.2022.08.021.
Article PubMed PubMed Central Google Scholar
Huang PS, Wang LY, Wang YW, Tsai MM, Lin TK, Liao CJ, et al. Evaluation and application of drug resistance by biomarkers in the clinical treatment of liver cancer. Cells. 2023. https://doi.org/10.3390/cells12060869.
Article PubMed PubMed Central Google Scholar
McGlynn KA, Petrick JL, El-Serag HB, John Wiley and Sons Inc. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(S1):4–13. https://doi.org/10.1002/hep.31288.
Article CAS PubMed Google Scholar
Rondanelli M, Faliva MA, Peroni G, Infantino V, Gasparri C, Iannello G, et al. Pivotal role of boron supplementation on bone health: a narrative review. J Trace Elem Med Biol. 2020. https://doi.org/10.1016/j.jtemb.2020.126577.
Barrón-González M, Montes-Aparicio AV, Cuevas-Galindo ME, Orozco-Suárez S, Barrientos R, Alatorre A, et al. Boron-containing compounds on neurons: actions and potential applications for treating neurodegenerative diseases. J Inorg Biochem. 2023. https://doi.org/10.1016/j.jinorgbio.2022.112027.
Omeroglu Ulu Z, Bolat ZB, Sahin F. Integrated transcriptome and in vitro analysis revealed anti-proliferative effect of sodium perborate on hepatocellular carcinoma cells. J Trace Elem Med Biol. 2022. https://doi.org/10.1016/j.jtemb.2022.127011.
Scorei R, Ciubar R, Ciofrangeanu CM, Mitran V, Cimpean A, Iordachescu D. Comparative effects of boric acid and calcium fructoborate on breast cancer cells. Biol Trace Elem Res. 2008;122(3):197–205. https://doi.org/10.1007/s12011-007-8081-8.
Article CAS PubMed Google Scholar
Gallardo-Williams MT, Chapin RE, King PE, Moser GJ, Goldsworthy TL, Morrison JP, Maronpot RR. Boron supplementation inhibits the growth and local expression of IGF-1 in human prostate adenocarcinoma (LNCaP) tumors in nude mice. Toxicol Pathol. 2004;32(1):73–8. https://doi.org/10.1080/01926230490260899.
Article CAS PubMed Google Scholar
Soleimani V, Sahebkar A, Hosseinzadeh H. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: review. Phytother Res. 2018;32(6):985–95. https://doi.org/10.1002/ptr.6054.
Article CAS PubMed Google Scholar
Dehzad MJ, Ghalandari H, Nouri M, Askarpour M, Academic Press. Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: a GRADE-assessed systematic review and dose–response meta-analysis of randomized controlled trials. Cytokine. 2023. https://doi.org/10.1016/j.cyto.2023.156144.
Hu P, Ke C, Guo X, Ren P, Tong Y, Luo S, et al. Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of Curcumin on hepatocellular carcinoma. Dig Liver Dis. 2019;51(1):120–6. https://doi.org/10.1016/j.dld.2018.06.012.
Article CAS PubMed Google Scholar
Liu F, Gao S, Yang Y, Zhao X, Fan Y, Ma W, et al. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway. Oncol Rep. 2018;39(3):1523–31. https://doi.org/10.3892/or.2018.6188.
Article CAS PubMed Google Scholar
Alhudaithi SS, Abul Kalam M, Binobaid L, Ali R, Almutairi MM, Qamar W, et al. Sorafenib and piperine co-loaded PLGA nanoparticles: development, characterization, and anti-cancer activity against hepatocellular carcinoma cell line. Saudi Pharm J. 2024. https://doi.org/10.1016/j.jsps.2024.102064.
Article PubMed PubMed Central Google Scholar
Kotb RR, Afifi AM, EL-Houseini ME, Ezz-Elarab M, Basalious EB, Omran MM, et al. The potential immuno-stimulating effect of curcumin, piperine, and taurine combination in hepatocellular carcinoma; a pilot study. Discov Oncol. 2023. https://doi.org/10.1007/s12672-023-00785-1.
Article PubMed PubMed Central Google Scholar
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B, Stockwell BR. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–72. https://doi.org/10.1016/j.cell.2012.03.042.
Article CAS PubMed PubMed Central Google Scholar
Ravari NR, Sadri F, Mahdiabadi MA, Mohammadi Y, Ourang Z, Rezaei Z. Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment. Front Cell Dev Biol. 2025;13:1522873. https://doi.org/10.3389/fcell.2025.1522873.
Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Signal Transduct Target Ther. 2024;9(1):271. https://doi.org/10.1038/s41392-024-01969-z.
Article PubMed PubMed Central Google Scholar
Sies H, Belousov VV, Chandel NS, Davies MJ, Jones DP, Mann GE, Murphy MP, Yamamoto M, Winterbourn C. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nat Rev Mol Cell Biol. 2022;23(7):499–515. https://doi.org/10.1038/s41580-022-00456-z.
Article CAS PubMed Google Scholar
Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A. 2016;113(34):E4966-75. https://doi.org/10.1073/pnas.1603244113.
Article CAS PubMed PubMed Central Google Scholar
Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C. Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci. 2023;24(1):449.
Chen K, Jiang X, Wu M, Cao X, Bao W, Zhu LQ, et al. Ferroptosis, a potential therapeutic target in Alzheimer’s disease. Front Cell Dev Biol. 2021. https://doi.org/10.3389/fcell.2021.704298.
Article PubMed PubMed Central Google Scholar
Chen Z, Wang W, Abdul Razak SR, Han T, Ahmad NH, Li X, et al. Ferroptosis as a potential target for cancer therapy. Cell Death Dis. 2023. https://doi.org/10.1038/s41419-023-05930-w.
Article PubMed PubMed Central Google Scholar
Zhou L, Han S, Guo J, Qiu T, Zhou J, Shen L, et al. Ferroptosis—a new dawn in the treatment of organ ischemia–reperfusion injury. Cells. 2022. https://doi.org/10.3390/cells11223653.
Article PubMed PubMed Central Google Scholar
Omeroglu Ulu Z, Degirmenci NS, Bolat ZB, Sahin F. Synergistic anti-cancer effect of sodium pentaborate pentahydrate, curcumin and piperine on hepatocellular carcinoma cells. Sci Rep. 2023. https://doi.org/10.1038/s41598-023-40809-y.
Article PubMed PubMed Central Google Scholar
Zhou N, Bao J. FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database. 2020. https://doi.org/10.1093/database/baaa021.
Article PubMed PubMed Central Google Scholar
Zou P, He Q, Xia H, Zhong W. Ferroptosis and its impact on common diseases. PeerJ. 2024;12:e18708. https://doi.org/10.7717/peerj.18708.
Article CAS PubMed PubMed Central Google Scholar
Lv L, Wang Y, Lv X, Miao Q. Involvement of HMGB1-mediated ferroptosis in systemic diseases. Front Cell Dev Biol. 2025;13:1676941. https://doi.org/10.3389/fcell.2025.1676941.
Comments (0)